Prevalence Of Hyperhomocysteinemia In Thai Chronic Kidney Disease (CKD) Patients
1 other identifier
observational
98
0 countries
N/A
Brief Summary
It is well recognized that patients with chronic kidney disease (CKD) have an increased risk for cardiovascular disease (CVD) and hyperhomocysteinemia appears to be a predictor of future CVD events. Hyperhomocysteinemia has been reported to bo of high prevalence in patients with CKD. The investigators aim to study the prevalence of hyperhomocysteinemia in Thai CKD patients by using Thai Screening and Early Evaluation of Kidney Disease (SEEK) study database and their relationship to CVD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2010
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 8, 2011
CompletedFirst Posted
Study publicly available on registry
July 12, 2011
CompletedJuly 12, 2011
May 1, 2010
5 months
July 8, 2011
July 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of Homocysteine
Level of homocysteinemia according to each CKD level
3 months
Secondary Outcomes (1)
Association of cardiovascular event to the level of homocysteine
3 months
Study Arms (2)
CKD stage 3-4
CKD stage 3-4 from Thai SEEK study
hyperhomocysteine group
CKD stage 3-4 from Thai SEEK study
Eligibility Criteria
Ninety eight subjects from CKD stages 3-4 were randomly sampling from Thai- SEEK study database. Thai-SEEK study is a community-based cross-sectional survey that was conducted between August 2007-june 2008 in four regions of Thailand (i.e Northern, Northeastern, Central and Southern) and Bangkok (Metropolitan).
You may qualify if:
- CKD stages 3-4 from Thai SEEK Study
You may not qualify if:
- CKD stage 5
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Ingsathit A, Thakkinstian A, Chaiprasert A, Sangthawan P, Gojaseni P, Kiattisunthorn K, Ongaiyooth L, Vanavanan S, Sirivongs D, Thirakhupt P, Mittal B, Singh AK; Thai-SEEK Group. Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study. Nephrol Dial Transplant. 2010 May;25(5):1567-75. doi: 10.1093/ndt/gfp669. Epub 2009 Dec 27.
PMID: 20037182BACKGROUND
Related Links
Biospecimen
serum
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thananda Trakarnvanich, M.D.
Renal Unit,Department of Medicine,Faculty of Medicine,Vajira Hospital,University of Bangkok Metropolis
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
July 8, 2011
First Posted
July 12, 2011
Study Start
June 1, 2010
Primary Completion
November 1, 2010
Study Completion
January 1, 2011
Last Updated
July 12, 2011
Record last verified: 2010-05